Indication intelligence, analysis and sector perception

RegMed Investors’ (RMi) pre-open: share pricing is disconnected from fundamentals

December 12, 2018 7:55am

Also, do sector investors think price targets are unassailable? My answer is they are … vulnerable, unreliable and unattainable!

After gains, there’s pain; followed by advances, declines and other progressions or was it regressions?

Pre-open indication: 1 BUY, 1 SELL and 1 HOLD

I answer one question, in which company should investors put, keep and commit their money!

In compiling my indication signals, specific knowledge of the sector and its practices as to lessons learned. It’s important for investors to identify and determine which indication is actually performance based.

Members only. Please login.

35 companies, 1 interpreter!

Insight, foresight and recommendation

What's Happening Today

5 hours 29 min ago
RegMed Investors (RMi) Closing Bell: racing to anther bottom

10 hours 15 min ago
RegMed Investors (RMi) - Q1/24 Cell and Gene Therapy Earnings Scorecard Results

14 hours 35 min ago
RegMed Investors’ (RMi) pre-open: optimism versus pessimism, each jimmied by sentiment fundamentals

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.